Oberland Capital Management is pumping some new life into Biohaven, striking a unique investment deal worth up to $600 ...

Three Senate Democrats called for an investigation into the developers of brain-computer interface devices, including ...

Ferrer’s R&D work focuses on neurological and pulmonary diseases, and the Spanish pharma has bought into ALS assets in the ...

In February, the HHS unexpectedly delivered notice that the South San Francisco-based company was to stop all work on the ...

Medtronic confirmed that its Hugo surgical robot system has been submitted to the FDA for review, alongside the successful completion of a large clinical trial evaluating its performance | According ...

The former head of Johnson & Johnson’s worldwide medtech business, Ashley McEvoy, has signed up to lead the insulin ...

The CEO of Novo Holdings has warned that his $160 billion fund will slow down investment activity until the dust settles ...

Tonix has no tonic for cocaine intoxication, with the biopharma terminating a midstage trial for the condition amid poor ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

Spruce Biosciences has swept away 55% of its employees. The biotech took the action days after inking a deal for a former ...

Transplanting bacteria from the feces of healthy people into the guts of mice and patients with fibromyalgia successfully ...

Pfizer has linked its PD-1 inhibitor to a 32% reduction in the risk of disease-related events in a phase 3 bladder cancer ...